| Bioactivity | Tigapotide (PCK-3145) is an anti-tumour peptide that reduces the development of skeletal metastases associated with prostate cancer. Tigapotide induces apoptosis and reduces tumour parathyroid hormone-related peptide (PTHrP) levels[1]. |
| Name | Tigapotide |
| CAS | 848084-83-3 |
| Shortening | EWQTDN-{Cys(Acm)}-ET-{Cys(Acm)}-T-{Cys(Acm)}-YET |
| Formula | C82H119N21O34S3 |
| Molar Mass | 2039.14 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Tigapotide
CAS: 848084-83-3 F: C82H119N21O34S3 W: 2039.14
Tigapotide (PCK-3145) is an anti-tumour peptide that reduces the development of skeletal metastases associated with pros
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.